# Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety

> **NCT05683223** · NA · RECRUITING · sponsor: **Boston University Charles River Campus** · enrollment: 240 (estimated)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Group CBT for Social Anxiety Disorder
- **DRUG:** Sertraline
- **BEHAVIORAL:** Individual CBT for Social Anxiety Disorder

## Key facts

- **NCT ID:** NCT05683223
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-26
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-06-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05683223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05683223, "Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05683223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*